Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10886
Title: Chronic administration of MK-801 and the NMDA receptor: further evidence for reduced sensitivity of the primary acceptor site from studies with the cortical wedge preparation.
Austin Authors: Beart, P M;Lodge, D
Affiliation: University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia
Issue Date: 1-May-1990
Publication information: The Journal of Pharmacy and Pharmacology; 42(5): 354-5
Abstract: Cortical slices removed from rats pre-treated with MK-901 0.5 mg kg-1 twice a day for 7 days had reduced responses to N-methyl-D-aspartate (NMDA) relative to quisqualate and glutamate compared with control animals. Potencies of competitive (CPMP) and non-competitive (ketamine) NMDA antagonists appeared unchanged. These changes are consistent with a reduced density of NMDA receptors.
Gov't Doc #: 1976785
URI: https://ahro.austin.org.au/austinjspui/handle/1/10886
Journal: The Journal of pharmacy and pharmacology
URL: https://pubmed.ncbi.nlm.nih.gov/1976785
Type: Journal Article
Subjects: Animals
Binding, Competitive.drug effects
Cerebral Cortex.drug effects.metabolism
Dizocilpine Maleate.pharmacology
Glutamates.pharmacology
In Vitro Techniques
Male
N-Methylaspartate.pharmacology
Quisqualic Acid.pharmacology
Rats
Rats, Inbred Strains
Receptors, N-Methyl-D-Aspartate.metabolism
Appears in Collections:Journal articles

Show full item record

Page view(s)

16
checked on Jul 16, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.